Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Glitazones

Glitazones

  • Diabetes (599)
    • Blood Glucose Meters (7)
    • Complications (108)
    • Diabetes in Pregnancy (4)
    • Diabetes Meds (73)
    • Drug-Induced Hypo/Hyperglycemia (99)
    • Monitoring (86)
    • Natural Medicines/Supplements (11)
    • Prevention (26)
    • Treatment (217)
      • Alpha-Glucosidase Inhibitors (21)
      • Amylin Agonist (10)
      • Bromocriptine (4)
      • Combination Products (17)
      • Gliptins (63)
      • Glitazones (72)
      • GLP-1 (31)
      • Incretin Enhancers/Mimetics (46)
      • Insulin (128)
      • Meglitinides (32)
      • Metformin (94)
      • SGLT2 Inhibitors (56)
      • Sulfonylureas (80)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (25)
  • Hypoglycemia (23)
  • Other (21)
  • Prediabetes (2)
  • Resources (132)
  • Thyroid Disorders (51)
31 - 45 of 72 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Overview of Nonalcoholic Fatty Liver Disease September 2017
Algorithm: Stepwise Treatment of Hypertension (Canada)

June 2017
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Chart: Canadian Cardiovascular Society Dyslipidemia Recommendations October 2016
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
Article: Ensure Fasting Patients With Diabetes Have Diabetic Testing Supplies May 2016
Patient Education: Diabetes and Fasting May 2016
Chart: How to Switch Insulin Products November 2015
Article: Stay Alert for Patients With Diabetes Being Switched to "2-In-1" Products June 2015
Chart: Drugs Associated with Weight Gain May 2015
Article: Stay Alert for Insulin Dosing Changes During Pregnancy April 2015
Article: Listen for Patients Complaining of Weight Gain With Meds April 2015
Commentary: Treatment of Gestational Diabetes April 2015
Article: Invokana (in-vo-KAHN-uh, canagliflozin) as the first in a new class of oral drugs for type 2 diabetes July 2014
Article: questions about when and how patients with type 2 diabetes should use insulin June 2014
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved